1. One-year outcomes of the U. S
One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study) 
Takao Ohki, MD, John F. Angle, MD, Hiroyoshi Yokoi, MD, Michael R. Jaff, DO, Jeffrey Popma, MD, Guy Piegari, MD, Yuji Kanaoka, MD Takao Ohki, MD, PhD, J. Fritz Angle, MD, Andrew Feiring, MD, Brian Nelson, MD, Marc Glickman, MD, Marcelo Guimaraes, MD, Patrick Hall, MD, Sarah Johnson, MD, William Jordan, MD, Omran Khoudoud, MD, Daniel Leung, MD, Joseph McGarvey, MD, James McKinsey, MD, Roman Nowygrod, MD, Nicolas Shammas, MD, Daniel Carey, MD, Srinivas Iyengar, MD, Daniel Isenbarger, MD, Vaqar Ali, MD, Majdi Ashchi, DO, Ernesto Rivera, MD, Mohammed Moursi, MD, William Bachinsky, MD, Christopher Metzger, MD, Guy Piegari, MD, Herbert Aronow, MD, Bret Wiechmann, MD, Christopher Callicutt, MD, Ian Gordon, PhD, MD, Peter Chaille, MD, Andrey Espinoza, MD, Malcolm Foster, MD, Mel Sharafuddin, MD, Rakesh Shah, MD, Frank Bunch, MD, Stuart Harlin, MD, Dr Masashi Iwabuchi, Dr Kenji Ando, Dr Kimihiko Kichikawa, Dr Toshiya Muramatsu, Dr Kazushi Urasawa, Dr Yoshiaki Yokoi, Dr Masaaki Uematsu, Dr Ping-Han Lo, Dr Chi-Hung Huang, Dr Hsien-Li Kao, Prof HwanJun Jae Takao Ohki, MD, John F. Angle, MD, Hiroyoshi Yokoi, MD, Michael R. Jaff, DO, Jeffrey Popma, MD, Guy Piegari, MD, Yuji Kanaoka, MD Takao Ohki, MD, PhD, J. Fritz Angle, MD, Andrew Feiring, MD, Brian Nelson, MD, Marc Glickman, MD, Marcelo Guimaraes, MD, Patrick Hall, MD, Sarah Johnson, MD, William Jordan, MD, Omran Khoudoud, MD, Daniel Leung, MD, Joseph McGarvey, MD, James McKinsey, MD, Roman Nowygrod, MD, Nicolas Shammas, MD, Daniel Carey, MD, Srinivas Iyengar, MD, Daniel Isenbarger, MD, Vaqar Ali, MD, Majdi Ashchi, DO, Ernesto Rivera, MD, Mohammed Moursi, MD, William Bachinsky, MD, Christopher Metzger, MD, Guy Piegari, MD, Herbert Aronow, MD, Bret Wiechmann, MD, Christopher Callicutt, MD, Ian Gordon, PhD, MD, Peter Chaille, MD, Andrey Espinoza, MD, Malcolm Foster, MD, Mel Sharafuddin, MD, Rakesh Shah, MD, Frank Bunch, MD, Stuart Harlin, MD, Dr Masashi Iwabuchi, Dr Kenji Ando, Dr Kimihiko Kichikawa, Dr Toshiya Muramatsu, Dr Kazushi Urasawa, Dr Yoshiaki Yokoi, Dr Masaaki Uematsu, Dr Ping-Han Lo, Dr Chi-Hung Huang, Dr Hsien-Li Kao, Prof HwanJun Jae 
Journal of Vascular Surgery 
Volume 63, Issue 2, Pages e1 (February 2016)
DOI: /j.jvs
Copyright © 2016 The Authors Terms and Conditions

2. Fig 1
Flow chart of subject accountability. DUS, Duplex ultrasound; PSVR, peak systolic velocity ratio.
Journal of Vascular Surgery  , e1DOI: ( /j.jvs )
Copyright © 2016 The Authors Terms and Conditions

3. Fig 2
Kaplan-Meier primary patency within 12 months. Primary patency was considered lost if the stent occluded, target lesion revascularization (TLR) was met, or peak systolic velocity ratio (PSVR) ≥2.5 m/s was met. CL, Confidence limits.
Journal of Vascular Surgery  , e1DOI: ( /j.jvs )
Copyright © 2016 The Authors Terms and Conditions